Immunological phenotype analysis of patients with Fanconi's anaemia and their family members

Acta Haematologica

Volumn 100, Issue 1, 1998, Pages 39-43

  Castello, Giuseppe ^a,d   Gallo, Ciro ^b,c   Napolitano, Maria ^a   Ascierto, Paolo A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Centro Elaborazione Dati Clinici del Mezzogiorno (CNR ACRO)   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Fanconi's anaemia; Immunologic phenotypes; Monoclonal antibodies

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; CHILD; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FANCONI ANEMIA; FEMALE; HELPER CELL; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ANTIGENS, CD; FANCONI ANEMIA; HLA-D ANTIGENS; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR;

EID: 0031829644     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040861     Document Type: Article

References (18)

1. Fanconi G: Familial constitutional panmyelocytopathy, Fanconi's anemia (FA). I. Clinical aspects. Semin Hematol 1967;4:233-240.
2. Schroeder TM, Tilgen D, Kruger J, Vogel F: Formal genetics of Fanconi's anemia. Hum Genet 1976;32:257-288.
3. Swift M: Fanconi's anaemia in the genetics of neoplasia. Nature 1971;230:370-373.
4. Cervenka J, Arthur D, Yasis C: Mitomycin C test for diagnostic differentiation of idiopathic aplastic anemia and Fanconi anemia. Pediatrics 1981;67:119-127.
5. Auerbach AD: Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 1993;21:731-733.
6. Hersey P, Edwards A, Lewis R, Kemp A, Mcinnes J: Deficient natural killer cell activity in a patient with Fanconi's anemia and squamous cell carcinoma: Association with defect in interferon release. Clin Exp Immunol 1982; 48:205-212.
7. Froom P, Aghai E, Dobinsky JB, Quitt M, Lahat N: Reduced natural killer activity in patients with Fanconi's anemia and in family members. Leuk Res 1987;11:197-199.
8. Gebbart E, Kysela D, Matthes H, Nikol M: Cytogenetic analyses utilizing various clastogens in two sibs with Fanconi anemia, their relatives and control individuals. Hum Genet 1985;69:309-315.
9. Rosselli F, Sanceau J, Wietzerbin J, Moustacchi E: Abnormal lymphokine production: A novel feature of the genetic disease of Fanconi anemia. Hum Genet 1992;89:42-48.
10. Rosselli F, Sanceau J, Gluckman E, Wietzerbin J, Moustacchi E: Abnormal lymphokine production: A novel feature of the genetic disease of Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor α. Blood 1994;83:1216-1225.
11. Wunder E, Thing Mortensen B, Schilling F, Henon PR: Anomalous plasma concentration and impaired secretion of growth factors in Fanconi's anemia. Stem Cells 1993;11(suppl 2):144-149.
12. Weisheimer K, Swift M: Congenital malformations and developmental disabilities in ataxiatelangiectasia, Fanconi anemia, and xeroderma pigmentosum families. Am J Hum Genet 1982; 34:781-793.
13. Auerbach AD, Alter BP: Prenatal and postnatal diagnosis of aplastic anemia; in Alter BP (ed): Perinatal Hematology: Methods in Hematology Series. Edinburgh, Churchill Livingstone, 1989, pp 225-251.
14. Duckworth-Rysiecki G, Hulten M, Mann J, Taylor AM: Clinical and cytogenetic diversity in Fanconi's anemia. J Med Genet 1984;21: 197-203.
15. Petridou M, Barret AJ: Physical and laboratory characteristics of heterozygote carriers of the Fanconi aplasia gene. Acta Paediatr Scand 1990;79:1069-1074.
16. Castello G, Ruocco V, Satriano RA, Zarrilli D: Role of interferons in the therapy of melanoma. Melanoma Res 1992;1:311-325.
17. BMDP: Statistical Software Manual. Berkeley, University of California Press, 1992.
18. Greenacre MJ: Correspondence Analysis in Practice. London. Academic Press, 1993.